BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 1689845)

  • 1. [Role of B-CD5 lymphocytes in the physiopathology of autoimmune diseases].
    Youinou P; Lydyard P
    Presse Med; 1990 Feb; 19(5):199-200. PubMed ID: 1689845
    [No Abstract]   [Full Text] [Related]  

  • 2. The importance of CD5-positive B cells in nonorgan-specific autoimmune diseases.
    Youinou P; Mackenzie L; Broker BM; Isenberg DI; Drogou-Lelong A; Gentric A; Lydyard PM
    Scand J Rheumatol Suppl; 1988; 76():243-9. PubMed ID: 2471999
    [TBL] [Abstract][Full Text] [Related]  

  • 3. CD5 positive B lymphocytes: a link between autoimmunity and B-cell oncogenesis.
    Bataille R; Klein B
    Anticancer Res; 1988; 8(4):707-10. PubMed ID: 2460021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Probing the human B-cell repertoire with EBV: polyreactive antibodies and CD5+ B lymphocytes.
    Casali P; Notkins AL
    Annu Rev Immunol; 1989; 7():513-35. PubMed ID: 2469441
    [No Abstract]   [Full Text] [Related]  

  • 5. CD5+ B lymphocytes in systemic lupus erythematosus and rheumatoid arthritis.
    Smith HR; Olson RR
    J Rheumatol; 1990 Jun; 17(6):833-5. PubMed ID: 1696993
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of human CD5 (Leu-1, OKT1)+ B lymphocytes and the antibodies they produce.
    Burastero SE; Casali P
    Contrib Microbiol Immunol; 1989; 11():231-62. PubMed ID: 2479500
    [No Abstract]   [Full Text] [Related]  

  • 7. Feedback suppression of normal and leukemic B cell colony growth by CD5+ B cells.
    Fernandez LA; MacSween JM; Robson DA
    Ann N Y Acad Sci; 1991; 628():379-81. PubMed ID: 1712559
    [No Abstract]   [Full Text] [Related]  

  • 8. B lymphocyte signaling pathways in systemic autoimmunity: implications for pathogenesis and treatment.
    Zouali M; Sarmay G
    Arthritis Rheum; 2004 Sep; 50(9):2730-41. PubMed ID: 15457440
    [No Abstract]   [Full Text] [Related]  

  • 9. The B-cell surface protein CD72/Lyb-2 is the ligand for CD5.
    Van de Velde H; von Hoegen I; Luo W; Parnes JR; Thielemans K
    Nature; 1991 Jun; 351(6328):662-5. PubMed ID: 1711157
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Immunologic phenotype of lymphocytes in chronic B-cell lymphocytic leukemia. I. B- and T-lymphocytes in chronic lymphocytic leukemia].
    Rupniewska ZM; Wach M; Kowal M; Roliński J; Antosz H
    Acta Haematol Pol; 1992; 23(1):21-7. PubMed ID: 1615748
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Normal B cell compartment in chronic lymphatic leukemia.
    Pluta A; Górski A; Nowaczyk M; Modlińska M
    Hematol Oncol; 1990; 8(3):121-4. PubMed ID: 1695606
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell surface antigen CD5 is a marker for activated human B cells.
    Werner-Favre C; Vischer TL; Wohlwend D; Zubler RH
    Eur J Immunol; 1989 Jul; 19(7):1209-13. PubMed ID: 2474446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The role of CDS+ of B-lymphocytes in the physiopathology of the hematopoietic system].
    Pluta A
    Pol Tyg Lek; 1992 Feb 3-10; 47(5-6):148-50. PubMed ID: 1279643
    [No Abstract]   [Full Text] [Related]  

  • 14. CD5+ B lymphocytes, polyreactive antibodies and the human B-cell repertoire.
    Casali P; Notkins AL
    Immunol Today; 1989 Nov; 10(11):364-8. PubMed ID: 2482031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CD5-positive B cells at the crossroads of B cell malignancy and nonorgan-specific autoimmunity.
    Youinou P; Pers JO; Jamin C; Lydyard PM
    Pathol Biol (Paris); 2000 Jul; 48(6):574-6. PubMed ID: 10965537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. B lymphocytes are required for development and treatment of autoimmune diseases.
    Youinou P; Jamin C; Pers JO; Berthou C; Saraux A; Renaudineau Y
    Ann N Y Acad Sci; 2005 Jun; 1050():19-33. PubMed ID: 16014517
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Genetic predisposition of autoimmune disease and B-cell chronic lymphocytic leukemia (B-CLL).
    Shirai T
    Tohoku J Exp Med; 1994 May; 173(1):133-40. PubMed ID: 7528945
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Genetic factors predisposing to B-CLL and to autoimmune disease in spontaneous murine model.
    Hirose S; Hamano Y; Shirai T
    Leukemia; 1997 Apr; 11 Suppl 3():267-70. PubMed ID: 9209361
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [At the crossroads between B lymphoproliferative syndromes to autoimmune diseases are CD5-positive B-lymphocytes: a new hypothesis].
    Youinou P
    Bull Acad Natl Med; 1999; 183(1):159-69; discussion 170. PubMed ID: 10371774
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CD5 positivity on peripheral blood B lymphocytes in patients with primary Sjögren's syndrome.
    Zeher M; Surányi P; Szegedi G
    Allergol Immunopathol (Madr); 1990; 18(2):75-8. PubMed ID: 1695475
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.